Neurolytixs

About:

Neurolytixs is a biotechnology company that develops health care technology to aid biomarker discovery for the diagnosis of concussions.

Website: https://www.neurolytixs.com

Top Investors: Techstars

Description:

Neurolytixs is a health care technology intended to aid biomarker discovery for the diagnosis of concussions. They have leveraged artificial intelligence to diagnose concussions with blood biomarker tests. They utilize machine learning, artificial intelligence, and blood tests, enabling the sports industry to better diagnose concussions on site.

Total Funding Amount:

$1.16M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2020-01-01

Founders:

Adrian Uthayagumaran, Douglas Fraser, Peter George

Number of Employees:

1-10

Last Funding Date:

2020-11-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai